An exaggerated emotional brain response to nonthreatening, nonemotional cues at age 14 predicted the onset of psychosis symptoms within the next 2 years.
RP5063, a dopamine serotonin stabilizer, was associated with symptom improvement in adults with acute exacerbation of schizophrenia or schizoaffective disorder.
Researchers performed a meta-analysis of data from 18 studies to determine if vitamin and mineral supplementation was effective at reducing psychiatric symptoms in patients with schizophrenia.
